| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | -0.0086 | 0.8 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | -0.0073 | 0.8 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | 0.0081 | 0.8 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | -0.0072 | 0.8 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | -0.0076 | 0.8 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | -0.0063 | 0.8 |
| mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | 0.0075 | 0.8 |
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | -0.008 | 0.8 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | -0.0074 | 0.8 |